Table 3 Transduction rates of inner ear hair cells after the injection of various AAV serotypes at early mature stage (P14-P18).
AAV2 | AAV8 | Anc80L65 | AAV9-PHP.eB | p | |
---|---|---|---|---|---|
IHC | n = 10 | n = 4 | n = 6 | n = 6 | |
Global | 82 ± 5.5 [53–100] | 72 ± 8.2 [55–96] | 99 ± 0.9 [94–100] | 98 ± 1.1 [93–100] | 0.009 |
Apex | 79 ± 9.7 [1-100] | 87 ± 7.6 [59–100] | 99 ± 0.5 [96–100] | 100 ± 0 [100–100] | 0.014 |
Medial turn | 83 ± 8.3 [20–100] | 77 ± 13.3 [51–100] | 100 ± 0 [100–100] | 100 ± 0 [100–100] | 0.085 |
Base | 83 ± 7.1 [40–100] | 58 ± 17.4 [10–93] | 97 ± 3.3 [83–100] | 94 ± 4.0 [80–100] | 0.079 |
OHC | n = 10 | n = 4 | n = 6 | n = 6 | |
Global | 29 ± 5.5 [4–58] | 3.4 ± 1.5 [0–7] | 7 ± 6.0 [0–31] | 26 ± 4.7 [10–39] | 0.007 |
Apex | 32 ± 8.1 [1–90] | 2 ± 1.7 [0–5] | 13 ± 8.9 [0–61] | 33 ± 6.1 [10–50] | 0.026 |
Medial turn | 37 ± 6.0 [10–65] | 8 ± 3.5 [0–14] | 1 ± 1.1 [0–4] | 22 ± 5.8 (10–42) | 0.004 |
Base | 19 ± 4.4 [1–36] | 1 ± 0.6 [0–2] | 0 | 24 ± 7.0 [5–39] | 0.003 |
VHC | n = 7 | n = 4 | n = 5 | n = 5 | |
Global | 1 ± 0.4 [0–5] | 8 ± 5.4 [0–34] | 37 ± 9.6 [0–90] | 25 ± 3.1 [6–38] | 0.0004 |
Ampulla | 1 ± 0.3 [0–2] | 13 ± 8.3 [0–34] | 15 ± 6.9 [0–32] | 24 ± 5.8 [6–38] | 0.0004 |
Macula | 1 ± 0.8 [0–5] | 4 ± 4 [0–24] | 58 ± 11.8 [31–90] | 26 ± 3.1 [18–35] | 0.003 |